Sclerostin antibody inhibits skeletal deterioration in mice exposed to partial weight-bearing.

[1]  A. Grauer,et al.  Romosozumab Treatment in Postmenopausal Women with Osteoporosis. , 2016, The New England journal of medicine.

[2]  Suojin Wang,et al.  Simulating the Lunar Environment: Partial Weightbearing and High-LET Radiation-Induce Bone Loss and Increase Sclerostin-Positive Osteocytes , 2016, Radiation Research.

[3]  S. Yakar,et al.  Osteocyte Apoptosis Caused by Hindlimb Unloading is Required to Trigger Osteocyte RANKL Production and Subsequent Resorption of Cortical and Trabecular Bone in Mice Femurs , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  Brian J. Stevenson,et al.  Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease. , 2016, The New England journal of medicine.

[5]  F. Ross,et al.  Transcriptional profiling of cortical versus cancellous bone from mechanically-loaded murine tibiae reveals differential gene expression. , 2016, Bone.

[6]  S. Borst,et al.  Sclerostin Inhibition Prevents Spinal Cord Injury‐Induced Cancellous Bone Loss , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  Rachel Eliman,et al.  Skeletal adaptation to reduced mechanical loading , 2014 .

[8]  Matthew R Allen,et al.  Partial weight bearing does not prevent musculoskeletal losses associated with disuse. , 2013, Medicine and science in sports and exercise.

[9]  R. Jilka,et al.  The relevance of mouse models for investigating age-related bone loss in humans. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[10]  M. Bouxsein,et al.  Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  Jordan Spatz,et al.  Partial reductions in mechanical loading yield proportional changes in bone density, bone architecture, and muscle mass , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  Scott M Smith,et al.  Benefits for bone from resistance exercise and nutrition in long‐duration spaceflight: Evidence from biochemistry and densitometry , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  G. Loots,et al.  Targeted deletion of Sost distal enhancer increases bone formation and bone mass , 2012, Proceedings of the National Academy of Sciences.

[14]  B. Macias,et al.  Simulated resistance training, but not alendronate, increases cortical bone formation and suppresses sclerostin during disuse. , 2012, Journal of applied physiology.

[15]  Matthew R Allen,et al.  Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. , 2012, Bone.

[16]  W. Jee,et al.  Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model. , 2011, Bone.

[17]  P. Kostenuik,et al.  Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  L. Young,et al.  Partial weight suspension: a novel murine model for investigating adaptation to reduced musculoskeletal loading. , 2010, Journal of applied physiology.

[19]  Ralph Müller,et al.  Guidelines for assessment of bone microstructure in rodents using micro–computed tomography , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  Daniel J Lightwood,et al.  Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  C. Galli,et al.  Osteocytes and WNT: the Mechanical Control of Bone Formation , 2010, Journal of dental research.

[22]  Guoyin Feng,et al.  Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β‐Catenin Signaling , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  Qing Chen,et al.  Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  A. Robling,et al.  Mechanical stimulation in vivo reduces osteocyte expression of sclerostin. , 2006, Journal of musculoskeletal & neuronal interactions.

[25]  Davide Zaffe,et al.  Size and density of osteocyte lacunae in different regions of long bones , 2006, Calcified Tissue International.

[26]  P. Beighton,et al.  0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(12):6392–6395 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2005-1235 Bone Mineral Density in Sclerosteosis; Affected Individuals and Gene Carriers , 2022 .

[27]  P. ten Dijke,et al.  SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. , 2005, Cytokine & growth factor reviews.

[28]  W. Van Hul,et al.  A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene. , 2005, Bone.

[29]  P. Beighton,et al.  The natural history of sclerosteosis , 2003, Clinical genetics.

[30]  D Vashishth,et al.  Determination of bone volume by osteocyte population , 2002, The Anatomical record.

[31]  D. Galas,et al.  A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. , 2002, American journal of medical genetics.

[32]  K. Lindpaintner,et al.  Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease , 2002, Journal of medical genetics.

[33]  D. Galas,et al.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. , 2001, American journal of human genetics.

[34]  M Dioszegi,et al.  Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). , 2001, Human molecular genetics.

[35]  Y. Murata,et al.  Changes in the markers of bone metabolism following skeletal unloading. , 1995, Environmental medicine : annual report of the Research Institute of Environmental Medicine, Nagoya University.